Milestone, excellent post and thanks for checking with TD. My comment is not meant to be negative to Joe, however I believe a phone call from him to Broadridge and/or OTC is warranted. I don't think anyone is monitoring the market cap of an OTC stock to see that it will go down by $52M overnight, so it won't take care of itself...IMHO. In a normal stock, one that is listed, when the share count changes, their earnings per share will either increase or decrease, which in turn decreases or increase the PE ratio. That is what traders who follow that stock will use to make purchasing decisions. So if we had a 15 PE and now we have a 10 PE, buyers might come in to buy. But we are not established yet nor on a major market to be watched by funds and institutional investors. On the OTC, I think the company needs to push for an adjustment, it one is allowed. Otherwise, Joe gave almost 1/3 of the company back to investors, but we will not get it and it just disappeared into the air. Like i mentioned earlier, had Joe known that, he could have gave those 20M shares to the existing shareholders now, so we would have more shares right now at this current price. But if he did that, then the OTC would have lowered the share price automatically for a dividend. It was a no win situation, but I feel it should be addressed by the company to the OTC.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.